drugset / Trial / NCT00548067

Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

NCT00548067

Phase 3 Completed 111 enrolled Novartis
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine potential pharmacokinetic drug-drug interaction when three drugs (valsartan, amlodipine, and hydrochlorothiazide) are co-administered.

Timeline

Start
2007-09
Primary completion
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Hydrochlorothiazide Unknown
Subject Valsartan Small molecule

Indications